RASSF1 and neoplasm: TNM staging is inextricably linked to tumour formation, progression and regression, with stage IV patients having the most advanced disease, resulting in hypermethylation of the promoter regions of oncogenes such as SHOX2 and RASSF1A and hypomethylation of the proto-oncogene PTGER4 gene [21].